pirfenidone has been researched along with Hypoxia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, N; Jiang, QG; Lin, JQ; Yan, LY; Yang, WZ; Zheng, H | 1 |
| Azuma, M; Imakura, T; Kagawa, K; Kawano, H; Koyama, K; Murakami, K; Naito, N; Nishimura, H; Nishioka, Y; Sato, S; Shinohara, T; Takahashi, N; Toyoda, Y | 1 |
| Bordenave, J; Cumont, A; Dorfmüller, P; Ghigna, MR; Guignabert, C; Huertas, A; Humbert, M; Phan, C; Poble, PB; Quatremare, T; Savale, L; Thuillet, R; Tu, L | 1 |
| Leask, A | 1 |
| Butera, G; Carlucci, A; Ceriana, P; Micheletti, A; Schreiber, A | 1 |
2 review(s) available for pirfenidone and Hypoxia
| Article | Year |
|---|---|
Distinct improvement of pulmonary function, ground-glass opacity, hypoxia and physical findings in an idiopathic pulmonary fibrosis patient after pirfenidone treatment : a case report with a review of the literature.
Topics: Humans; Hypoxia; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones; Tomography, X-Ray Computed | 2020 |
Getting to the heart of the matter: new insights into cardiac fibrosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Atrophy; Cicatrix; Connective Tissue Growth Factor; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Humans; Hypoxia; Models, Cardiovascular; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Platelet-Derived Growth Factor; Pyridones; Rats; Signal Transduction; Transforming Growth Factor beta | 2015 |
3 other study(ies) available for pirfenidone and Hypoxia
| Article | Year |
|---|---|
Effect and mechanism of pirfenidone combined with 2-methoxy-estradiol perfusion through portal vein on hepatic artery hypoxia-induced hepatic fibrosis.
Topics: 2-Methoxyestradiol; Animals; Collagen; Fibrosis; Hepatic Artery; Hypoxia; Liver Cirrhosis; Matrix Metalloproteinase 2; Perfusion; Portal Vein; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2023 |
Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.
Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Extracellular Matrix; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Male; Muscle, Smooth, Vascular; Pulmonary Artery; Pyridones; Rats; Rats, Wistar; Vascular Remodeling | 2019 |
An Unusual Case of Hypoxemia Improving Overnight in Idiopathic Pulmonary Fibrosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Echocardiography, Transesophageal; Foramen Ovale, Patent; Humans; Hypoxia; Idiopathic Pulmonary Fibrosis; Lung; Male; Pyridones; Septal Occluder Device; Tomography, X-Ray Computed | 2015 |